The Effect of Short Term Amiodarone Treatment on Success Rate and Quality of Life After Catheter Ablation for Atrial Fibrillation.

Trial Profile

The Effect of Short Term Amiodarone Treatment on Success Rate and Quality of Life After Catheter Ablation for Atrial Fibrillation.

Completed
Phase of Trial: Phase IV

Latest Information Update: 24 Jul 2017

At a glance

  • Drugs Amiodarone (Primary)
  • Indications Atrial fibrillation
  • Focus Therapeutic Use
  • Acronyms AMIO-CAT
  • Most Recent Events

    • 24 Jul 2017 Results (n=102) of subpopulation assessing mid-regional pro-atrial natriuretic peptide and N-terminal pro brain natriuretic peptide in patients undergoing ablation for atrial fibrillation, published in the American Journal of Cardiology.
    • 21 Aug 2013 Planned end date changed from 1 Nov 2013 to 1 Jan 2014 as reported by ClinicalTrials.gov.
    • 21 Aug 2013 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top